Dropout · post‐traumatic stress disorder (PTSD)
Stand‐alone couple or family therapy showed no clear difference in treatment dropout (treatment acceptability) compared with no treatment (low certainty).
1 finding from 1 review
Acceptability of the intervention (as measured by participants not attending · adults
Pharmacy‐based management (pharmacist with or without wider team) showed no clear difference in acceptability of the intervention (as measured by participants not… compared with treatment (low certainty).
1 finding from 1 review
Intervention not reported
Acceptability of treatment (17 weeks) · women with a history of postnatal depression
1 finding from 1 review
Intervention not reported
Acceptability of treatment (17 weeks) · women with a history of postnatal depression
1 finding from 1 review
Treatment acceptability: dropouts from treatment · children and adolescents, 11 to 18 years old, with mental health problems
It is very uncertain whether client feedback changes treatment acceptability: dropouts from treatment compared with no client feedback (very low certainty).
1 finding from 1 review
Secondary outcome: acceptability of treatment · children and adolescents, aged 10 to 18 years, with long‐term physical conditions
1 finding from 1 review
Acceptability. Participants experiencing troublesome adverse effects of any nature · adults with acute affective episodes in bipolar disorder
Topiramate as add‐on therapy showed no clear difference in acceptability with topiramate (endpoint: 12 weeks) Number of… compared with placebo (low certainty).
1 finding from 1 review
Acceptability. Participants experiencing troublesome adverse effects of any nature · adults with acute affective episodes in bipolar disorder
Topiramate as monotherapy showed no clear difference in acceptability with topiramate (12 weeks) Number of participants… compared with an alternative drug (low certainty).
1 finding from 1 review
Acceptability. Participants experiencing troublesome adverse effects of any nature · adults with acute affective episodes in bipolar disorder
It is very uncertain whether topiramate as add‐on therapy changes acceptability with topiramate (8 weeks) Number of participants… compared with alternative drug (very low certainty).
1 finding from 1 review
Acceptability. Participants experiencing troublesome adverse effects of any nature · adults with acute affective episodes in bipolar disorder
Topiramate showed no clear difference in acceptability with topiramate (endpoint: 12 weeks) Number of… compared with placebo (low certainty).
1 finding from 1 review
Acceptability. Participants experiencing troublesome adverse effects of any nature · depression in adults
S‐adenosyl methionine as monotherapy may leads to lower acceptability. Participants experiencing troublesome adverse effects… compared with tricyclic antidepressant agent (low certainty).
1 finding from 1 review
Secondary outcome: acceptability of treatment · depression in adults
S‐adenosyl methionine as monotherapy showed no clear difference in acceptability Participants dropping out of treatment during the… compared with SSRI antidepressant agent (low certainty).
1 finding from 1 review
Acceptability. Participants experiencing troublesome adverse effects of any nature · depression in adults
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Secondary outcome: acceptability of treatment · depression in adults
It is very uncertain whether S‐adenosyl methionine as adjunctive treatment changes acceptability Participants dropping out of treatment during the… compared with placebo (very low certainty).
1 finding from 1 review
Secondary outcome: acceptability of treatment · depression in adults
S‐adenosyl methionine as monotherapy showed no clear difference in acceptability Participants dropping out of treatment during the… compared with placebo (low certainty).
1 finding from 1 review
Acceptability. Participants experiencing troublesome adverse effects of any nature · depression in adults
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Acceptability. Participants experiencing troublesome adverse effects of any nature · depression in adults
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Secondary outcome: acceptability of treatment · depression in adults
It is very uncertain whether S‐adenosyl methionine as monotherapy changes acceptability Participants dropping out of treatment during the… compared with tricyclic antidepressant agent (very low certainty).
1 finding from 1 review
Secondary outcome: acceptability of treatment · people with anxiety and comorbid alcohol use disorders
It is very uncertain whether paroxetine changes treatment acceptability compared with placebo (very low certainty).
1 finding from 1 review
Treatment withdrawal · adults with anxiety disorders
DCS and cognitive and behavioural therapies showed no clear difference in treatment acceptability: withdrawals from treatment compared with placebo and cognitive and behavioural therapies (moderate certainty).
1 finding from 1 review